LIPOSANA
Live / Registered — Registered (as of 18 Jun 2024)
What this means for you
Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Jun 2030: the §8 declaration of use).
Record
- Serial number
- 97363473
- Registration number
- 7422748
- Mark type
- Word mark
- Filed
- 14 Apr 2022
- Published for opposition
- 21 Mar 2023
- Registered
- 18 Jun 2024
- Next maintenance filing
- §8 declaration of use, due by 18 Jun 2030 (grace period to 18 Dec 2030)
- Attorney of record
- Scott D. Marty
Goods and services
- Class 005 — Pharmaceuticals: Human allograft tissue composed of lyophilized adipose for medical treatment of soft tissue defect
Owner
- Britecyte Inc., Columbia, MD, US
- Britecyte Inc., Columbia, MD, US
- Britecyte Inc., Columbia, MD, US
Prosecution history
- 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 10 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 10 May 2024 — SU-EXAMINER'S AMENDMENT WRITTEN
- 01 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 May 2024 — NON-FINAL ACTION E-MAILED
- 01 May 2024 — SU - NON-FINAL ACTION - WRITTEN
- 24 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Apr 2024 — ASSIGNED TO LIE
- 05 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED